TRANSARTERIAL CHEMOEMBOLIZATION
Clinical trials for TRANSARTERIAL CHEMOEMBOLIZATION explained in plain language.
Never miss a new study
Get alerted when new TRANSARTERIAL CHEMOEMBOLIZATION trials appear
Sign up with your email to follow new studies for TRANSARTERIAL CHEMOEMBOLIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for bile duct cancer patients who failed chemo: triple therapy shows promise
Disease control CompletedThis study tested a combination of three treatments—drug-coated beads placed directly into the liver tumor, an oral targeted drug (apatinib), and an immunotherapy (PD-1 antibody)—in 20 adults with advanced intrahepatic cholangiocarcinoma (a type of bile duct cancer) that had wors…
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Phase: PHASE2 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Disease control
Last updated Jun 08, 2026 13:13 UTC
-
New pain cocktail eases suffering in liver cancer procedure
Symptom relief CompletedThis study looked at whether a combination of two pain medicines (hydromorphone and flurbiprofen) given through a vein can better control pain after a liver cancer treatment called TACE. 129 patients with intermediate-to-advanced liver cancer took part. The goal was to see if thi…
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Phase: PHASE4 • Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Symptom relief
Last updated Jun 09, 2026 12:06 UTC
-
CT scans may guide better liver cancer treatment choices
Knowledge-focused CompletedThis study looked at 324 liver cancer patients to see if CT scan features could predict who would benefit from adding a targeted drug to standard chemo-embolization therapy. The goal was to improve treatment decisions by identifying patients most likely to respond. The study did …
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:05 UTC
-
AI model helps decide: extra chemo or just watchful waiting for liver cancer?
Knowledge-focused CompletedThis study looked at over 1000 liver cancer patients who had surgery to see if adding a treatment called TACE (a type of chemo delivered directly to the liver) helps prevent the cancer from coming back. Using machine learning, researchers created a tool to predict which patients …
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Sponsor: Anhui Provincial Hospital • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:03 UTC